Corporate Tech Investors

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is a corporate venture capital group that partners with startup ventures that can advance its organizational interests.

Venture Investor Overview

Contact Information

Background Information

Overview

Regeneron is a leading science and technology company delivering life-transforming medicines for serious diseases. Founded by physician-scientists 30 years ago, our science-driven approach has resulted in six FDA-approved medicines and numerous product candidates in a range of diseases, including asthma, pain, cancer and infectious diseases.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/18/2022

Transaction History

Our records indicate that Regeneron Pharmaceuticals invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Leonard Schleifer

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Regeneron Pharmaceuticals has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Refinery29 | Reignwood Group

Share this article

About Our Corporate Tech Investor Database

Our corporate equity investment data comes from VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary